Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants

Neonatology

Volumn 95, Issue 2, 2009, Pages 97-104

  Ng, Pak C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Erythromycin; Gastrointestinal dysmotility; Preterm infants

Indexed keywords

ERYTHROMYCIN;

CHOLESTASIS; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG MEGADOSE; ENTERIC FEEDING; GASTROINTESTINAL MOTILITY DISORDER; HEART ARRHYTHMIA; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; HYPERTROPHY; LOW DRUG DOSE; LUNG DISEASE; MULTIDRUG RESISTANCE; PARENTERAL NUTRITION; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; PYLORUS STENOSIS; QT PROLONGATION; REVIEW; SEPTICEMIA; UREAPLASMA INFECTION;

ADMINISTRATION, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROMYCIN; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 59849115357     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000153093     Document Type: Review

References (41)

1. Kaufman SS, Gondolesi GE, Fishbein TM: Parenteral nutrition associated liver disease. Semin Neonatal 2003;8:375-381.
2. Teitelbaum DH: Parenteral nutrition-associated cholestasis. Curr Opin Pediatr 1997;9:270-275.
3. Ng PC, Brownlee KG, Dear PRF: Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia. Arch Dis Child 1991;66:1164-1166.
4. Ng PC, Fok TF, So KW, Wong W, Yip PK, Liu K: Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia. Pediatr Surg Int 1997;12:211-212.
5. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, Donovan EF, Oh W, Bauer CR, Saha S, Poole WK, Stoll BJ; National Institute of Child Health and Human Development Neonatal Research Network: Adverse effect of early dexamethasone in extremely-low-birth-weight infants. N Engl J Med 2001;344:95-101.
6. Ng PC, Li K, Wong RPO, Chui KM, Wong E, Fok TF: Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants. Pediatr Res 2002;51:296-303.
7. Kelly DA: Liver complications of pediatric parenteral nutrition: epidemiology. Nutrition 1998;14:153-157.
8. Andorsky DJ, Lund DP, Lillehei CW, Jaksic T, Dicanzio J, Richardson DS, Collier SB, Lo C, Duggan C: Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001;139:27-33.
9. Ng PC, Fok TF, Lee CH, Wong W, Cheung KL: Erythromycin treatment for gastrointestinal dysmotility in preterm infants. J Paediatr Child Health 1997;33:148-150.
10. Stenson BJ, Middlemist L, Lyon AJ: Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1998;79:F212-F214.
11. Patole SK, Almonte R, Kadalraja R, Tuladhar R, Muller R, Whitehall JS: Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates? Int J Clin Pract 2000;54:504-508.
12. Oei J, Lui K: A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants. Acta Paediatr 2001;90:904-908.
13. ElHennawy AA, Sparks JW, Armentrout D, Huseby V, Berseth CL: Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants. J Pediatr Gastroenterol Nutr 2003;37:281-286.
14. Ng SC, Gomez JM, Rajadurai VS, Saw SM, Quak SH: Establishing enteral feeding in preterm infants with feeding intolerance: a randomized controlled study of low-dose erythromycin. J Pediatr Gastroenterol Nutr 2003;37:554-558.
15. Cairns P, Craig S, Tubman R, Roberts RS, Wilson J, Schmidt B: Randomised controlled trial of low-dose erythromycin in preterm infants with feed intolerance (abstract). Pediatr Res 2002;51:379A-380A.
16. Aly H, Abdel-Hady H, Khashaba M, El-Badry N: Erythromycin and feeding intolerance in premature infants: a randomized trial. J Perinatol 2007;27:39-43.
17. Nuntnarumit P, Kiatchoosakun P, Tantiprapa W, Boonkasidecha S: Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants. J Pediatr 2006;148:600-605.
18. Ng PC, So KW, Fung KSC, Lee CH, Fok TF, Wong E, Wong W, Cheung KL, Cheng AFB: Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. Arch Dis Child Fetal Neonatal Ed 2001;84:F177-F182.
19. Ng PC, Lee CH, Wong SPS, Lam HS, Liu FYB, So KW, Lee CY, Fok TF: High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants. Gastroenterology 2007;132:1726-1739.
20. Ng E, Shah V: Erythromycin for feeding intolerance in preterm infants. Cochrane Data System Rev 2001;2:CD001815.
21. Sørensen HT, Skriver MV, Pedersen L, Larsen H, Ebbesen F, Schønheyder HC: Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis 2003;35:104-106.
22. Mabanta CG, Pryhuber GS, Weinberg GA, Phelps DL: Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Data System Rev 2003;4:CD003744.
23. Jadcherla SR, Klee G, Berseth CL: Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants. Pediatr Res 1997;42:365-369.
24. Mathis C, Malbert CH: Changes in pyloric resistance induced by erythromycin. Neurogastroenterol Motil 1998;10:131-138.
25. Coulie B, Tack J, Peeters T, Janssens J: Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in human. Gut 1998;43:395-400.
26. Varannes SBD, Parys V, Ropert A, Chayvialle JA, Roze C, Galmiche JP: Erythromycin enhances fasting and postprandial proximal gastric tone in humans. Gastroenterology 1995;109:32-39.
27. Jannssens J, Peeters T, Vantrappen G, Tack J, Urbain JL, De Roo M, Muls E, Bouillon R: Improvement of gastric emptying in diabetic gastroparesis by erythromycin. N Engl J Med 1990;322:1028-1031.
28. Holle GE, Steinbach E, Forth W: Effects of erythromycin in the dog upper gastrointestinal tract. Am J Physiol 1992;263:G52-G59.
29. Otterson MF, Sarna SK: Gastrointestinal motor effects of erythromycin. Am J Physiol 1990;259:G355-G363.
30. Tack J, Janssens J, Vantrappen G, Peeters T, Annese V, Depoortere I, Muls E, Bouillon R: Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 1992;103:72-79.
31. Fraser R, Shearer T, Fuller J, Horowitz M, Dent J: Intravenous erythromycin overcomes small intestinal feedback on antral, pyloric, and duodenal motility. Gastroenterology 1992;103:114-119.
32. Parkman HP, Pagano AP, Vozzelli MA, Ryan JP: Gastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in rabbit stomach. Am J Physiol 1995;269:G418-G426.
33. Annese V, Janssens J, Vantrappen G, Tack J, Peeters TL, Willemse P, Van Cutsem E: Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastro-duodenal coordination. Gastroenterology 1992;102:823-828.
34. Costalos C, Gounaris A, Varhalama E, Kokori F, Alexiou N, Kolovou E: Erythromycin as a prokinetic agent preterm infants. J Pediatr Gastroenterol Nutr 2002;34:23-25.
35. Bisset WM, Watt JB, Rivers RPA, Milla PJ: Ontogeny of fasting small intestinal motor activity in the human infant. Gut 1988;29:483-488.
36. Berseth CL: Gestational evolution of small intestinal motility in preterm and term infants. J Pediatr 1989;115:646-651.
37. Tomomasa T, Miyazaki M, Koizumi T, Kuroume T: Erythromycin increases gastric antral motility in human premature infants. Biol Neonate 1993;63:349-352.
38. Tomomasa T, Tabata M, Nako Y, Kaneko H, Morikawa A: The effect of oral erythromycin on gastric emptying in neonates with gastric retention (abstract). Gastroenterology 1997;112(suppl):A839.
39. Jadcherla SR, Berseth CL: Effect of erythromycin on gastroduodenal contractile activity in developing neonates. J Pediatr Gastroenterol Nutr 2002;34:16-22.
40. Verhagen MAMT, Samsom M, Maes B, Geypens BJ, Ghoos YF, Smout AJ: Effects of new motilide, ABT-229, on gastric emptying and post-prandial antroduodenal motility in healthy volunteers. Aliment Pharmacol Ther 1997;11:1077-1086.
41. Nieuenhuijs VB, van Duijvenbode-Beumer H, Verheem A, Visser MR, Verhoef J, Gooszen HG, Akkermans LM: The effects of ABT-229 and octreotide on interdigestive small bowel motility, bacterial overgrowth and bacterial translocation in rats. Eur J Clin Invest 1999;29:33-40.